Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

• Published in: Journal of translational medicine Vol. 19; no. 1; p. 213
• Main Authors: Wang, Lei, Liu, Yan, Yu, Zhengtao, Gong, Jianwu, Deng, Zhiyong, Ren, Nianjun, Zhong, Zhe, Cai, Hao, Tang, Zhi, Cheng, Haofeng, Chen, Shuai, He, Zhengwen
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 17.05.2021; BioMed Central; BMC
• Subjects: Apoptosis; Biomarker; Biomarkers; Brain cancer; Cell culture; Cell growth; Cell migration; Cell proliferation; Cell Proliferation - genetics; Central nervous system; Computer programs; Development and progression; DNA microarrays; Experiments; Flow cytometry; GABRA1; Gene expression; Gene Expression Regulation, Neoplastic; Genetic aspects; Genomes; Glioma; Glioma - genetics; Glioma cells; Gliomas; Health aspects; Humans; Invasion; Medical prognosis; Medical research; MicroRNA; MicroRNAs; MicroRNAs - genetics; Migration; MiR-139-5p; miRNA; Neoplasia; Neurotransmitter receptors; Physiological aspects; Post-transcription; Prognosis; Proteins; Receptors, GABA-A; Software; Survival analysis; Therapeutic targets; Transcriptome; Transcriptomes; γ-Aminobutyric acid; China; United States > US; MiR-139-5p; GABRA1; Biomarker; Glioma; Migration; Proliferation; Invasion; Apoptosis
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-021-02880-9

Glioma is an extremely aggressive malignant neoplasm of the central nervous system. MicroRNA (miRNA) are known to bind to specific target mRNA to regulate post-transcriptional gene expression and are, therefore, currently regarded as promising biomarkers for glioma diagnosis and prognosis. The aim of the present study was to examine the pathogenesis and potential molecular markers of glioma by comparing the differential expression of miRNA and mRNA between glioma tissue and peritumor brain tissue. We explored the impact of screened core miRNA and mRNA on cell proliferation, invasion, and migration of glioma. An miRNA expression profile dataset (GSE90603) and a transcriptome profile dataset (GSE90598) were downloaded from combined miRNA-mRNA microarray chips in the Gene Expression Omnibus (GEO) database. Overall, 59 differentially expressed miRNAs (DEMs) and 419 differentially expressed genes (DEGs) were identified using the R limma software package. FunRich software was used to predict DEM target genes and miRNA-gene pairs, and Perl software was used to find overlapping genes between DEGs and DEM target genes. There were 129 overlapping genes regulated by nine miRNAs between target genes of the DEMs and DEGs. The Chinese Glioma Genome Atlas(CGGA) was analyzed in order to identify miRNAs with diagnostic and prognostic significance. MiR-139-5p, miR-137, and miR-338-3p were validated to be significantly linked to prognosis in glioma patients. Finally, we validated that miR-139-5p affected glioma malignant biological behavior via targeting gamma-aminobutyric acid A receptor alpha 1(GABRA1) through rescue experiments. Low miR-139-5p expression was correlated with survival probability and World Health Organization (WHO) grade. MiR-139-5p overexpression inhibited cell proliferation, migration, and invasion of glioma in vitro. GABRA1 was identified as a functional downstream target of miR-139-5p. Decreased GABRA1 expression was related to similar biological roles as miR-139-5p overexpression while upregulation of GABRA1 effectively reversed the inhibition effects of miR-139-5p. These results demonstrate a novel axis for miR-139-5p/GABRA1 in glioma progression and provide potential prognostic predictors and therapeutic target for glioma patients.